Navigating Compliance Challenges in Pharma Sales

I’ve been noticing that as we push for greater market penetration, the regulatory landscape is evolving rapidly. For instance, staying compliant while meeting targets has become more challenging since the recent updates in FDA guidelines. How are others adjusting their strategies to maintain compliance without sacrificing sales performance?

‌⁠‍⁠​‍​‍‌⁠‌​​‍​‍​⁠‍‍​‍​‍‌‍⁠‌‌‍‌‌‌‍‌​‌‍‍‌‌‍​⁠‌‍​‌‌‍⁠​‌⁠​⁠‌‍​‌‌‍⁠​‌‍‌‌‌⁠​⁠​‍​‍​‍⁠​​‍​‍‌‍‍⁠​‍​‍​⁠‍‍​‍​‍‌‍⁠‍‌‍‌‌‌⁠‌⁠‌‌⁠⁠‌⁠‌​‌‍⁠⁠‌⁠​​‌‍‍‌‌‍​⁠​‍​‍​‍⁠​​‍​‍‌‍‍‌‌‍‌​​‍​‍​⁠‍‍​‍​‍‌‍⁠‍‌‍‌‌‌⁠‌⁠​‍​‍​‍⁠​​‍​‍‌‍‌​​‍​‍​⁠‍‍​‍​‍​⁠​‍​⁠​​​⁠​‍​⁠‌‍​⁠​​​⁠‌‍​⁠​​​⁠​‌​‍​‍​‍⁠​​‍​‍‌‍‍​​‍​‍​⁠‍‍​‍​‍‌‌‍‌​⁠​⁠‌⁠‌⁠‌‍‍‍‌⁠‌⁠‌‌‍​‌‌​‍​‍⁠‌​‍⁠‌‌‍‍⁠​⁠​⁠‌‍​‍‌‌‍‍‌​‌⁠‌‍⁠‌‌⁠​⁠​‍​‍‌⁠⁠‌​​

It’s like trying to juggle while walking a tightrope — gotta keep your focus! One approach I’ve found helpful is collaborating closely with compliance teams early on, so everyone’s on the same page. How are you balancing those tough deadlines with compliance?

‌⁠‍⁠​‍​‍‌⁠‌​​‍​‍​⁠‍‍​‍​‍‌‍⁠‌‌‍‌‌‌‍‌​‌‍‍‌‌‍​⁠‌‍​‌‌‍⁠​‌⁠​⁠‌‍​‌‌‍⁠​‌‍‌‌‌⁠​⁠​‍​‍​‍⁠​​‍​‍‌‍‍⁠​‍​‍​⁠‍‍​‍​‍‌⁠​‍‌‍‌‌‌⁠​​‌‍⁠​‌⁠‍‌​‍​‍​‍⁠​​‍​‍‌‍‍‌‌‍‌​​‍​‍​⁠‍‍​⁠​⁠​⁠​‌​⁠‍​​‍⁠​​‍​‍‌‍‌​​‍​‍​⁠‍‍​‍​‍​⁠​‍​⁠​​​⁠​‍​⁠‌‍​⁠​​​⁠‌‍​⁠​​​⁠​‍​‍​‍​‍⁠​​‍​‍‌‍‍​​‍​‍​⁠‍‍​‍​‍​⁠‌‍‌‌‍‍‌⁠‍​‌​‌⁠​⁠‌⁠‌⁠​‌‌⁠‍‌‌‌‌​‌‍‌​‌​‌‌‌‌‌‍‌​⁠‌‌‌‌‌​⁠‌‍​⁠‍​‌​​⁠​‍​‍‌⁠⁠‌​​